ARDS生物学亚表型模型在亚洲人群中的泛化性:一项国际多中心前瞻性生物标志物研究
研究前瞻性纳入北京(97%汉族)和匹兹堡(90%高加索人)的ARDS患者,评估6种已建立的亚表型分类器在亚洲人群中的泛化性。结果显示各模型预测的亚表型比例总体相似,但模型间一致性差;亚洲队列中符合柏林定义的ARDS患者炎症水平高于HFNC-ARDS患者。
要点
- 已建立ARDS亚表型分类器在亚洲患者中预测的亚表型分布与高加索人群相似。
- 不同模型间一致性差,提示模型变异性需进一步研究。
- 亚洲队列中柏林定义ARDS患者炎症水平高于HFNC-ARDS患者。
核心结论
- 已建立的ARDS亚表型分类器在亚洲患者中显示出相似的亚表型分布,但模型间一致性差,需进一步研究模型变异性以接近临床实施。
研究设计与样本
- 国际多中心前瞻性生物标志物研究,2011至2020年纳入北京和匹兹堡ARDS患者共356例,北京队列测37种蛋白生物标志物,匹兹堡队列测10种重叠标志物。
主要发现
- 各模型预测的高炎症与低炎症亚表型比例在不同队列间总体相似。
- 观察到模型间一致性差。
- 亚洲队列中柏林定义ARDS患者炎症水平高于HFNC-ARDS患者。
关键数值与推荐
- 北京队列97%为汉族亚洲人,匹兹堡队列90%为高加索人。
- 83%患者符合柏林定义,其余为符合新全球定义的HFNC患者。
- 基线低氧血症严重程度可比但结局不同。
临床怎么用
- 在亚洲ARDS患者中应用现有亚表型分类器时需注意模型间一致性差的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Subphenotype classifiers for acute respiratory distress syndrome (ARDS) dichotomise patients into hyperinflammatory versus hypoinflammatory subgroups. These models demonstrated prognostic and predictive values but were developed primarily in Caucasian populations. Generalisability of these models in Asian patients, who experience worse clinical outcomes, has not been established. We aimed to profile host responses in Asian patients with ARDS and evaluate the generalisability of established classifiers in this understudied population compared with a Caucasian cohort. METHODS: We prospectively enrolled patients with ARDS from medical intensive care units in Beijing, China, and Pittsburgh, Pennsylvania, USA. In the Beijing cohort, 37 protein biomarkers were measured, with 10 overlapping biomarkers measured in the Pittsburgh cohort. Six established subphenotype models were assessed for generalisability and intermodel agreement. Sensitivity analyses, including latent class analysis, were conducted to explore biological heterogeneity within Asians. RESULTS: Between 2011 and 2020, a total of 356 patients with ARDS (83% meeting the Berlin Definition; the rest on high-flow nasal cannula (HFNC) meeting the New Global Definition) were enrolled across Beijing (97% Han Asian) and Pittsburgh (90% Caucasian) sites, with comparable baseline hypoxaemia severity but disparate outcome. While the proportion of hyperinflammatory versus hypoinflammatory subphenotypes was predicted to be overall similar across different cohorts per each model, we observed poor intermodel agreement. We observed heightened inflammation in Berlin patients with ARDS compared with HFNC-ARDS within our Asian cohort. CONCLUSION: Established subphenotype classifiers demonstrated similar distribution of subphenotypes in Asian patients with ARDS. However, poor intermodel agreement highlights the need for further investigation into model variability with models coming closer to bedside implementation. TRIAL REGISTRATION NUMBER: NCT02975908.
引用
- Yang H, Xia J, Huang X, et al. Generalisability of ARDS biological subphenotype models in Asians: an international, multicentre, prospective biomarker study. Thorax. 2026. PMID: 41167619. doi:10.1136/thorax-2025-223421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。